{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:51:07Z","timestamp":1791820267930,"version":"4.3.4"},"reference-count":85,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Subst\ufffdAbuse"],"published-print":{"date-parts":[[2015,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>While a number of pharmacological interventions exist for the treatment of opioid use disorder, evidence evaluating the effect of pain on substance use behavior, attrition rate, and physical or mental health among these therapies has not been well established. We aim to evaluate these effects using evidence gathered from a systematic review of studies evaluating chronic non-cancer pain (CNCP) in patients with opioid use disorder.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched the Medline, EMBASE, PubMed, PsycINFO, Web of Science, Cochrane Database of Systematic Reviews, ProQuest Dissertations and theses Database, Cochrane Central Register of Controlled Trials, World Health Organization International Clinical Trials Registry Platform Search Portal, and National Institutes for Health Clinical Trials Registry databases to identify articles evaluating the impact of pain on addiction treatment outcomes for patients maintained on opioid agonist therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Upon screening 3,540 articles, 14 studies with a combined sample of 3,128 patients fulfilled the review inclusion criteria. Results from the meta-analysis suggest that pain has no effect on illicit opioid consumption [pooled odds ratio (pOR): 0.70, 95%CI 0.41\u20131.17; I\n                      <jats:sup>2<\/jats:sup>\n                      = 0.0] but a protective effect for reducing illicit non-opioid substance use (pOR: 0.57, 95%CI 0.41\u20130.79; I\n                      <jats:sup>2<\/jats:sup>\n                      = 0.0). Studies evaluating illicit opioid consumption using other measures demonstrate pain to increase the risk for opioid abuse. Pain is significantly associated with the presence of psychiatric disorders (pOR: 2.18; 95%CI 1.6, 2.9; I\n                      <jats:sup>2<\/jats:sup>\n                      = 0.0%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>CNCP may increase risk for continued opioid abuse and poor psychiatric functioning. Qualitative synthesis of the findings suggests that major methodological differences in the design and measurement of pain and treatment response outcomes are likely impacting the effect estimates.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4137\/sart.s30120","type":"journal-article","created":{"date-parts":[[2015,9,10]],"date-time":"2015-09-10T16:35:41Z","timestamp":1441902941000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":24,"title":["Impact of Chronic Pain on Treatment Prognosis for Patients with Opioid Use Disorder: A Systematic Review and Meta-analysis"],"prefix":"10.4137","volume":"9","author":[{"given":"Brittany B.","family":"Dennis","sequence":"first","affiliation":[{"name":"Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada."},{"name":"Population Genomics Program, Chanchlani Research Centre, McMaster University, Hamilton, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Bawor","sequence":"additional","affiliation":[{"name":"Population Genomics Program, Chanchlani Research Centre, McMaster University, Hamilton, ON, Canada."},{"name":"McMaster Integrative Neuroscience Discovery and Study (MiNDS) Program, McMaster University, Hamilton, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leen","family":"Naji","sequence":"additional","affiliation":[{"name":"Michael G. Degroote School of Medicine, McMaster University, Hamilton, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol K.","family":"Chan","sequence":"additional","affiliation":[{"name":"School of Medicine and Medical Science, University College Dublin, Dublin, Ireland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaymie","family":"Varenbut","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, Western University, London, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Paul","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada."},{"name":"Department of Anesthesia, McMaster University, Hamilton, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Varenbut","sequence":"additional","affiliation":[{"name":"Canadian Addiction Treatment Centres, Richmond Hill, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Daiter","sequence":"additional","affiliation":[{"name":"Canadian Addiction Treatment Centres, Richmond Hill, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Plater","sequence":"additional","affiliation":[{"name":"Canadian Addiction Treatment Centres, Richmond Hill, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Pare","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Marsh","sequence":"additional","affiliation":[{"name":"Canadian Addiction Treatment Centres, Richmond Hill, ON, Canada."},{"name":"Northern Ontario School of Medicine, Sudbury, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Worster","sequence":"additional","affiliation":[{"name":"Canadian Addiction Treatment Centres, Richmond Hill, ON, Canada."},{"name":"Department of Medicine, Hamilton General Hospital, Hamilton, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipika","family":"Desal","sequence":"additional","affiliation":[{"name":"Canadian Addiction Treatment Centres, Richmond Hill, ON, Canada."},{"name":"Population Health Research Institute, Hamilton Health Sciences, Hamilton, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lehana","family":"Thabane","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada."},{"name":"Population Health Research Institute, Hamilton Health Sciences, Hamilton, ON, Canada."},{"name":"Departments of Pediatrics and Anesthesia, McMaster University, Hamilton, ON Canada."},{"name":"Centre for Evaluation of Medicine,"},{"name":"Biostatistics Unit, Father Sean O'Sullivan Research Centre, St Joseph's Healthcare, Hamilton, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainab","family":"Samaan","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada."},{"name":"Department of Psychiatry and Behavioral Neurosciences, McMaster University, Hamilton, ON, Canada."},{"name":"Peter Boris Centre for Addictions Research, Hamilton, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2015,9,10]]},"reference":[{"key":"bibr1-SART.S30120","first-page":"S1","volume":"3","author":"Classification of chronic pain.","year":"1986","journal-title":"Pain Suppl."},{"key":"bibr2-SART.S30120","doi-asserted-by":"publisher","DOI":"10.7326\/M14-2559"},{"key":"bibr3-SART.S30120","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2008.04.027"},{"key":"bibr4-SART.S30120","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-011-1648-2"},{"key":"bibr5-SART.S30120","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-152-11-201006010-00004"},{"issue":"166","key":"bibr6-SART.S30120","first-page":"1","author":"Chen L.H.","year":"2014","journal-title":"NCHS data brief."},{"key":"bibr7-SART.S30120","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.369"},{"key":"bibr8-SART.S30120","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa1406143"},{"key":"bibr9-SART.S30120","doi-asserted-by":"crossref","unstructured":"AhmadiJ. A controlled trial of buprenorphine treatment for opium dependence: the first experience from Iran. Drug and alcohol dependence. 2002; 66(2): 111\u20134. http:\/\/onlinelibrary.wiley.com\/o\/cochrane\/clcentral\/articles\/791\/CN-00384791\/frame.html","DOI":"10.1016\/S0376-8716(01)00202-2"},{"key":"bibr10-SART.S30120","doi-asserted-by":"publisher","DOI":"10.1007\/BF02915283"},{"issue":"2","key":"bibr11-SART.S30120","first-page":"1","volume":"7","author":"Ahmadi J.F.H.","year":"2004","journal-title":"German Journal of Psychiatry."},{"key":"bibr12-SART.S30120","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2007.01935.x"},{"key":"bibr13-SART.S30120","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.63.2.210"},{"key":"bibr14-SART.S30120","doi-asserted-by":"crossref","unstructured":"EderH., JagschR., KraigherD., PrimoracA., EbnerN., FischerG. Comparative study of the effectiveness of slow-release morphine and methadone for opioid maintenance therapy. Addiction (Abingdon, England). 2005; 100(8): 1101\u20139. http:\/\/onlinelibrary.wiley.com\/o\/cochrane\/clcentral\/articles\/083\/CN-00529083\/frame.html","DOI":"10.1111\/j.1360-0443.2005.001128.x"},{"key":"bibr15-SART.S30120","doi-asserted-by":"crossref","unstructured":"EissenbergT., BigelowG.E., StrainE.C. Dose-related efficacy of levomethadyl acetate for treatment of opioid dependence. A randomized clinical trial. JAMA: the journal of the American Medical Association. 1997; 277(24): 1945\u201351. http:\/\/onlinelibrary.wiley.com\/o\/cochrane\/clcentral\/articles\/955\/CN-00140955\/frame.html","DOI":"10.1001\/jama.1997.03540480045037"},{"key":"bibr16-SART.S30120","doi-asserted-by":"crossref","unstructured":"FischerG., GombasW., EderH. Buprenorphine versus methadone maintenance for the treatment of opioid dependence. Addiction (Abingdon, England). 1999; 94(9): 1337\u201347. http:\/\/onlinelibrary.wiley.com\/o\/cochrane\/clcentral\/articles\/437\/CN-00265437\/frame.html","DOI":"10.1046\/j.1360-0443.1999.94913376.x"},{"key":"bibr17-SART.S30120","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022164"},{"key":"bibr18-SART.S30120","doi-asserted-by":"publisher","DOI":"10.1100\/tsw.2005.52"},{"issue":"4","key":"bibr19-SART.S30120","first-page":"2","volume":"11","author":"Guo S.","year":"2001","journal-title":"Hong Kong Journal of Psychiatry"},{"key":"bibr20-SART.S30120","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.106.026112"},{"key":"bibr21-SART.S30120","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1980.01780210035003"},{"key":"bibr22-SART.S30120","doi-asserted-by":"crossref","unstructured":"JaffeJ.H., SenayE.C., SchusterC.R., RenaultP.R., SmithB., DiMenzaS. Methadyl acetate vs methadone. A double-blind study in heroin users. JAMA : the journal of the American Medical Association. 1972; 222(4): 437\u201342. http:\/\/onlinelibrary.wiley.com\/o\/cochrane\/clcentral\/articles\/696\/CN-00007696\/frame.html","DOI":"10.1001\/jama.1972.03210040013004"},{"key":"bibr23-SART.S30120","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(95)01186-2"},{"key":"bibr24-SART.S30120","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1992.03480200058024"},{"key":"bibr25-SART.S30120","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12600-1"},{"key":"bibr26-SART.S30120","unstructured":"KamienJ.B., BranstetterS.A., AmassL. Buprenorphine-naloxone versus methadone maintenance therapy: A randomised double-blind trial with opioid-dependent patients. Heroin Addiction and Related Clinical Problems. 2008; 10(4): 5\u201318. http:\/\/onlinelibrary.wiley.com\/o\/cochrane\/clcentral\/articles\/368\/CN-00754368\/frame.html"},{"key":"bibr27-SART.S30120","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2006.05.014"},{"key":"bibr28-SART.S30120","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-199306000-00004"},{"key":"bibr29-SART.S30120","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2002.00090.x"},{"key":"bibr30-SART.S30120","unstructured":"KrupitskyE., ZvartauE., BlokhinaE. Randomized trial of long-acting sustained-release naltrexone implant vs oral naltrexone or placebo for preventing relapse to opioid dependence. Archives of general psychiatry. 2012; 69(9): 973\u201381. http:\/\/onlinelibrary.wiley.com\/o\/cochrane\/clcentral\/articles\/942\/CN-00841942\/frame.html"},{"key":"bibr31-SART.S30120","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2004.02.002"},{"key":"bibr32-SART.S30120","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2006.05.005"},{"key":"bibr33-SART.S30120","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1998.9344753.x"},{"key":"bibr34-SART.S30120","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1976.01770060043007"},{"key":"bibr35-SART.S30120","doi-asserted-by":"crossref","unstructured":"LingW., WessonD.R., CharuvastraC., KlettC.J. A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence. Archives of general psychiatry. 1996; 53(5): 401\u20137. http:\/\/onlinelibrary.wiley.com\/o\/cochrane\/clcentral\/articles\/562\/CN-00124562\/frame.html","DOI":"10.1001\/archpsyc.1996.01830050035005"},{"key":"bibr36-SART.S30120","doi-asserted-by":"publisher","DOI":"10.1080\/10550490490440799"},{"key":"bibr37-SART.S30120","doi-asserted-by":"crossref","unstructured":"MarchJ.C., Oviedo-JoekesE., Perea-MillaE., CarrascoF. Controlled trial of prescribed heroin in the treatment of opioid addiction. Journal of substance abuse treatment. 2006; 31(2): 203\u201311. http:\/\/onlinelibrary.wiley.com\/o\/cochrane\/clcentral\/articles\/751\/CN-00571751\/frame.html","DOI":"10.1016\/j.jsat.2006.04.007"},{"key":"bibr38-SART.S30120","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2003.00335.x"},{"key":"bibr39-SART.S30120","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-005-2239-x"},{"key":"bibr40-SART.S30120","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0810635"},{"key":"bibr41-SART.S30120","doi-asserted-by":"publisher","DOI":"10.1111\/j.1465-3362.2009.00100.x"},{"key":"bibr42-SART.S30120","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(00)80006-X"},{"key":"bibr43-SART.S30120","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.18.2370"},{"key":"bibr44-SART.S30120","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2003.08.007"},{"key":"bibr45-SART.S30120","first-page":"2239","volume":"10","author":"Dennis B.B.","year":"2014","journal-title":"Neuropsychiatric disease and treatment."},{"key":"bibr46-SART.S30120","doi-asserted-by":"publisher","DOI":"10.1080\/10550490902772470"},{"key":"bibr47-SART.S30120","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2005.09.005"},{"key":"bibr48-SART.S30120","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2013.10.007"},{"key":"bibr49-SART.S30120","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2014.05.066"},{"key":"bibr50-SART.S30120","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-015-0042-2"},{"key":"bibr51-SART.S30120","doi-asserted-by":"publisher","DOI":"10.1177\/001316446002000104"},{"key":"bibr52-SART.S30120","volume-title":"Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies.","author":"National Institutes of Health.","year":"2014"},{"key":"bibr53-SART.S30120","unstructured":"WellsG.A. S.B., O'ConnellD., PetersonJ., WelchV., LososM. The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses.\n                      Available from\n                      : http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.htm. 2009."},{"key":"bibr54-SART.S30120","unstructured":"CollaborationT.C. Research Projects: Cochrane Risk of Bias tool. 2013; http:\/\/bmg.cochrane.org\/research-projectscochrane-risk-bias-tool"},{"key":"bibr55-SART.S30120","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.04.026"},{"key":"bibr56-SART.S30120","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2700"},{"key":"bibr57-SART.S30120","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.15.2008"},{"key":"bibr58-SART.S30120","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.07.001"},{"key":"bibr59-SART.S30120","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.091716"},{"key":"bibr60-SART.S30120","doi-asserted-by":"publisher","DOI":"10.1016\/0740-5472(92)90062-S"},{"key":"bibr61-SART.S30120","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1998.9312185711.x"},{"issue":"4","key":"bibr62-SART.S30120","first-page":"719","volume":"22","author":"Mantel N.","year":"1959","journal-title":"J Natl Cancer Inst."},{"key":"bibr63-SART.S30120","unstructured":"The Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration 2011."},{"key":"bibr64-SART.S30120","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2004.11.011"},{"key":"bibr65-SART.S30120","author":"Dhingra L.","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"bibr66-SART.S30120","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.08m04367"},{"issue":"6","key":"bibr67-SART.S30120","first-page":"E739","volume":"16","author":"Bounes V.","year":"2013","journal-title":"Pain Physician."},{"key":"bibr68-SART.S30120","doi-asserted-by":"crossref","unstructured":"ChakrabartiA., WoodyG.E., GriffinM.L., SubramaniamG., WeissR.D. Predictors of buprenorphine-naloxone dosing in a 12-week treatment trial for opioid-dependent youth: secondary analyses from a NIDA Clinical Trials Network study. Drug and alcohol dependence. 2010; 107(2-3): 253\u20136. http:\/\/onlinelibrary.wiley.com\/o\/cochrane\/clcentral\/articles\/172\/CN-00743172\/frame.html","DOI":"10.1016\/j.drugalcdep.2009.10.014"},{"key":"bibr69-SART.S30120","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2012.12.010"},{"key":"bibr70-SART.S30120","doi-asserted-by":"publisher","DOI":"10.1111\/pme.12430"},{"key":"bibr71-SART.S30120","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2011.638734"},{"key":"bibr72-SART.S30120","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(99)00144-X"},{"key":"bibr73-SART.S30120","doi-asserted-by":"publisher","DOI":"10.1080\/10550887.2012.759872"},{"key":"bibr74-SART.S30120","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2014.07.009"},{"key":"bibr75-SART.S30120","volume-title":"Methadone Maintenance Treatment Program Standards and Clinical Guidelines.","year":"2011"},{"key":"bibr76-SART.S30120","unstructured":"National Guideline C. VA\/DoD clinical practice guideline for management of substance use disorders (SUD). http:\/\/www.guideline.gov\/content.aspx?id=15676&search=methadone. Accessed September 29, 2014."},{"key":"bibr77-SART.S30120","unstructured":"National Guideline C. Buprenorphine\/naloxone for opioid dependence: clinical practice guideline. http:\/\/www.guideline.gov\/content.aspx?id=39351&search=methadone. Accessed September 10, 2014."},{"key":"bibr78-SART.S30120","volume-title":"Drug Misuse: Opioid Detoxification.","author":"NCCMH.","year":"2008"},{"issue":"2","key":"bibr79-SART.S30120","doi-asserted-by":"crossref","first-page":"145","DOI":"10.36076\/ppj.2011\/14\/145","volume":"14","author":"Lee M.","year":"2011","journal-title":"Pain Physician."},{"key":"bibr80-SART.S30120","doi-asserted-by":"publisher","DOI":"10.1093\/acprof:oso\/9780199231881.001.0001"},{"key":"bibr81-SART.S30120","volume-title":"The Brief Pain Inventory: User Guide.","author":"Cleeland C.","year":"1991"},{"key":"bibr82-SART.S30120","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(00)00200-3"},{"key":"bibr83-SART.S30120","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2012.684621"},{"key":"bibr84-SART.S30120","doi-asserted-by":"publisher","DOI":"10.1111\/pme.12520"},{"key":"bibr85-SART.S30120","doi-asserted-by":"publisher","DOI":"10.5055\/jom.2006.0041"}],"container-title":["Substance Abuse: Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.4137\/SART.S30120","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.4137\/SART.S30120","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.4137\/SART.S30120","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T05:58:23Z","timestamp":1777615103000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.4137\/SART.S30120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":85,"alternative-id":["10.4137\/SART.S30120"],"URL":"https:\/\/doi.org\/10.4137\/sart.s30120","relation":{},"ISSN":["1178-2218","1178-2218"],"issn-type":[{"value":"1178-2218","type":"print"},{"value":"1178-2218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1]]},"article-number":"SART.S30120"}}